Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3
Closed -$185 373
2025
Q1
$185 Buy
+3
New +$199 ﹤0.01% 424
2023
Q4
Sell
-2
Closed -$138 434
2023
Q3
$138 Buy
+2
New +$151 ﹤0.01% 596
2020
Q2
Sell
-6
Closed 356
2020
Q1
$0 Buy
+6
New +$286 ﹤0.01% 387

Other funds holding HOLX

Perkins Coie Trust Company's HOLX Position: Q2 2025 in Review

Perkins Coie Trust Company sold out of Hologic (HOLX) in Q2 2025, closing a stake of 3 shares — an estimated $185 sold.

Perkins Coie Trust Company first reported a position in HOLX in Q1 2020 and held it in 3 quarters. The position peaked at $185 in Q1 2025. 693 funds tracked by Wall St. Rank hold HOLX as of Q2 2025.

  • Perkins Coie Trust Company reported no remaining Hologic position as of Q2 2025 after selling out during the quarter.
  • Perkins Coie Trust Company sold 3 Hologic shares in Q2 2025, an estimated $185.
  • Perkins Coie Trust Company first reported a position in Hologic in Q1 2020 and held it in 3 quarters.
  • Perkins Coie Trust Company's Hologic position peaked at $185 in Q1 2025.
  • 693 funds tracked by Wall St. Rank held Hologic as of Q2 2025.

Based on Perkins Coie Trust Company's 13F filing for Q2 2025, filed 10 Jul 2025.